首页> Discover oncology> A novel mitochondrial-related lncRNA signature mediated prediction of overall survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer patients.

A novel mitochondrial-related lncRNA signature mediated prediction of overall survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hao,Xiong

第一单位： Department of Urology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, 353000, China.

作者： Hao,Xiong ^[1] ; Cheng,Lin ^[1] ; Xiang,Huang ^[1] ; Hao,Wang ^[2]

作者单位： Department of Urology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, 353000, China. ^[1] Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, China. wanghao872013@163.com. ^[2]

关键词 Bladder cancer Chemotherapeutic Immune landscape Mitochondrial dysfunction Prognostic risk model

DOI 10.1007/s12672-024-01108-8

PMID 38907134

发布时间 2024-06-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Discover oncology

2024年15卷1期

239页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Discover oncology

2024年15卷1期

239页

检索历史清除

A novel mitochondrial-related lncRNA signature mediated prediction of overall survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer patients.

Discover oncology

相似文献

同项目论文

Discover oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel mitochondrial-related lncRNA signature mediated prediction of overall survival, immune landscape, and the chemotherapeutic outcomes for bladder cancer patients.

Discover oncology

相似文献

同项目论文

Discover oncology

相关期刊

检索历史清除